FI811967L - 2,3-bis-hydroxibenzylderivat - Google Patents

2,3-bis-hydroxibenzylderivat

Info

Publication number
FI811967L
FI811967L FI811967A FI811967A FI811967L FI 811967 L FI811967 L FI 811967L FI 811967 A FI811967 A FI 811967A FI 811967 A FI811967 A FI 811967A FI 811967 L FI811967 L FI 811967L
Authority
FI
Finland
Prior art keywords
hydroxibenzylderivat
bis
Prior art date
Application number
FI811967A
Other languages
English (en)
Finnish (fi)
Inventor
Marinus Bernard Groen
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI811967L publication Critical patent/FI811967L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/04—Seven-membered rings not condensed with other rings
    • C07D321/06—1,3-Dioxepines; Hydrogenated 1,3-dioxepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI811967A 1980-06-24 1981-06-23 2,3-bis-hydroxibenzylderivat FI811967L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8020688 1980-06-24

Publications (1)

Publication Number Publication Date
FI811967L true FI811967L (fi) 1981-12-25

Family

ID=10514289

Family Applications (1)

Application Number Title Priority Date Filing Date
FI811967A FI811967L (fi) 1980-06-24 1981-06-23 2,3-bis-hydroxibenzylderivat

Country Status (10)

Country Link
US (1) US4343796A (el)
EP (1) EP0043150A1 (el)
JP (1) JPS5732239A (el)
AU (1) AU7203281A (el)
DK (1) DK267781A (el)
ES (1) ES8300663A1 (el)
FI (1) FI811967L (el)
GR (1) GR75694B (el)
PT (1) PT73240B (el)
ZA (1) ZA813951B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
US5439899A (en) * 1993-03-10 1995-08-08 Purdue Research Foundation Cosalane and related compounds having activity against aids and aids-related infections
CO4780021A1 (es) * 1996-03-29 1999-05-26 Tanabe Seiyaku Co Derivados de butadieno y procedimiento para la preparacion de los mismos
US7528166B2 (en) 2002-02-05 2009-05-05 Hormos Medical Corporation Lignan derivatives
US7811312B2 (en) * 2002-12-04 2010-10-12 Morphographics, Lc Bone alignment implant and method of use
TWI466667B (zh) * 2012-06-12 2015-01-01 Joben Bio Medical Co Ltd 芝麻素衍生物抗神經傷害之用途
CN103520143B (zh) * 2012-07-02 2016-02-03 乔本生医股份有限公司 一种神经保护性组合物及其应用

Also Published As

Publication number Publication date
AU7203281A (en) 1982-01-07
ES503338A0 (es) 1982-11-01
JPS5732239A (en) 1982-02-20
GR75694B (el) 1984-08-02
DK267781A (da) 1981-12-25
EP0043150A1 (en) 1982-01-06
ES8300663A1 (es) 1982-11-01
US4343796A (en) 1982-08-10
PT73240B (en) 1984-10-22
ZA813951B (en) 1982-06-30
PT73240A (en) 1981-07-01

Similar Documents

Publication Publication Date Title
FI831664A0 (fi) 1,3-dioxan-5-ylalkenoylsyror
DK587183A (da) 1,4-benzodiazepin-derivater
DK165695C (da) 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol
IT1194789B (it) 25-idrossi-26,26,26,27,27,27-esafluorocolecalciferolo
BE888310A (fr) 3-amidino-ansamycines,
IT8121126A0 (it) 1 alfa-idrossi-2beta-fluorocolecalciferolo.
DK155594C (da) 3,3-dimethyl-1-phenoxybutan-2-oler
FI811967L (fi) 2,3-bis-hydroxibenzylderivat
DE3365097D1 (de) 6,7-dihydro-7,7-disubstituted-khellins
FI812210L (fi) Stabiliserade 1,1,1-trikloretansammansaettningar
IT8349567A0 (it) 2,2,2-trialogeno-1-(trialogenometiletiliden-bis-benzen-tioli
IT1152515B (it) 5-fenossifenil-tetraidro-1,3,5-tiadiazin-4-oni
DE3360666D1 (de) 2,6-dicyanoanilines
DE3175752D1 (de) 1,3-dihalopropan-2-ols
FI810242L (fi) 1,3-diformyloxi-2-brom-nitropropan
FI811704L (fi) Metyl-kinoxalin-1,4-dioxid-derivat
IT1189011B (it) 1,4;3,6-dinanidro-2,5-diazido-2,5-dideossi-esitoli
DK157002C (da) 1,3-dihalogenpropan-2-oler
DE3175756D1 (de) 3,5,12-trihydroxy-6,11-dioxonaphthacenes
IT1141257B (it) Chinazoline 2,4,6,7-tetrasostituite
FI822823A0 (fi) 2,9-dioksatrisyklo-(4,3,1,0 )-dekaner
DE3134423A1 (de) Ciferol 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
IT8049853A0 (it) 6-alfa-fluoro-prednisolone 17,21diesteri
TR21560A (tr) Etilsulfonilmetil-i,3 ogzazolidin herbisid antidot
FI821159L (fi) 2,4-dioxacyclohexanonderivat

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: AKZO N.V.